Global metabolic interaction network of the human gut microbiota for context-specific community-scale analysis

Abstract

A system-level framework of complex microbe–microbe and host–microbe chemical cross-talk would help elucidate the role of our gut microbiota in health and disease. Here we report a literature-curated interspecies network of the human gut microbiota, called NJS16. This is an extensive data resource composed of ∼570 microbial species and 3 human cell types metabolically interacting through >4,400 small-molecule transport and macromolecule degradation events. Based on the contents of our network, we develop a mathematical approach to elucidate representative microbial and metabolic features of the gut microbial community in a given population, such as a disease cohort. Applying this strategy to microbiome data from type 2 diabetes patients reveals a context-specific infrastructure of the gut microbial ecosystem, core microbial entities with large metabolic influence, and frequently produced metabolic compounds that might indicate relevant community metabolic processes. Our network presents a foundation towards integrative investigations of community-scale microbial activities within the human gut.

Full text

Its licence does not allow us to show the full text. Read it at PubMed Central:

References 70

1. 1.

   Nowak M. A. Evolutionary Dynamics: exploring the Equations of Life Harvard Univ. Press (2006 ).

   Not in our library

2. 2.
   Feedback between Population and Evolutionary Dynamics Determines the Fate of Social Microbial Populations · 2013

   No notice
3. 3.

   Mackie R. I., White B. A. & Isaacson R. E. Gastrointestinal Microbiology Chapman & Hall (1997 ).

   Not in our library

4. 4.

   Blaut M. Ecology and physiology of the intestinal tract. Curr. Top. Microbiol. Immunol. 358, 247–272 (2013 ).

   Not in our library10.1007/82_2011_192

5. 5.

   Qin J.. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464, 59–65 (2010 ).

   Not in our library10.1038/nature08821

6. 6.

   Turnbaugh P. J.. The human microbiome project. Nature 449, 804–810 (2007 ).

   Not in our library10.1038/nature06244

7. 7.

   Donohoe D. R.. The microbiome and butyrate regulate energy metabolism and autophagy in the mammalian colon. Cell Metab. 13, 517–526 (2011 ).

   Not in our library10.1016/j.cmet.2011.02.018

8. 8.

   Furusawa Y.. Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature 504, 446–450 (2013 ).

   Not in our library10.1038/nature12721

9. 9.

   Louis P., Hold G. L. & Flint H. J. The gut microbiota, bacterial metabolites and colorectal cancer. Nat. Rev. Microbiol. 12, 661–672 (2014 ).

   Not in our library10.1038/nrmicro3344

10. 10.

    Gevers D.. The treatment-naive microbiome in new-onset Crohn's disease. Cell Host Microbe 15, 382–392 (2014 ).

    Not in our library10.1016/j.chom.2014.02.005

11. 11.

    Kostic A. D.. Genomic analysis identifies association of Fusobacterium with colorectal carcinoma. Genome Res. 22, 292–298 (2012 ).

    Not in our library10.1101/gr.126573.111

12. 12.

    Qin J.. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 490, 55–60 (2012 ).

    Not in our library10.1038/nature11450

13. 13.

    Turnbaugh P. J.. A core gut microbiome in obese and lean twins. Nature 457, 480–484 (2009 ).

    Not in our library10.1038/nature07540

14. 14.

    Barabasi A.-L., Gulbahce N. & Loscalzo J. Network medicine: a network-based approach to human disease. Nat. Rev. Genet. 12, 56–68 (2011 ).

    Not in our library10.1038/nrg2918

15. 15.

    Hood L. Tackling the microbiome. Science 336, 1209 (2012 ).

    Not in our library10.1126/science.1225475

16. 16.
    Microbial Co-occurrence Relationships in the Human Microbiome · 2012

    No notice
17. 17.
    Inferring Correlation Networks from Genomic Survey Data · 2012

    No notice
18. 18.

    Greenblum S., Turnbaugh P. J. & Borenstein E. Metagenomic systems biology of the human gut microbiome reveals topological shifts associated with obesity and inflammatory bowel disease. Proc. Natl Acad. Sci. USA 109, 594–599 (2012 ).

    Not in our library10.1073/pnas.1116053109

19. 19.
    Metabolic Reconstruction for Metagenomic Data and Its Application to the Human Microbiome · 2012

    No notice
20. 20.

    Levy R. & Borenstein E. Metabolic modeling of species interaction in the human microbiome elucidates community-level assembly rules. Proc. Natl Acad. Sci. USA 110, 12804–12809 (2013 ).

    Not in our library10.1073/pnas.1300926110

21. 21.

    Zelezniak A.. Metabolic dependencies drive species co-occurrence in diverse microbial communities. Proc. Natl Acad. Sci. USA 112, 6449–6454 (2015 ).

    Not in our library10.1073/pnas.1421834112

22. 22.

    Heinken A. & Thiele I. Systematic prediction of health-relevant human-microbial co-metabolism through a computational framework. Gut Microbes 6, 120–130 (2015 ).

    Not in our library10.1080/19490976.2015.1023494

23. 23.

    Kettle H., Louis P., Holtrop G., Duncan S. H. & Flint H. J. Modelling the emergent dynamics and major metabolites of the human colonic microbiota. Environ. Microbiol. 17, 1615–1630 (2015 ).

    Not in our library10.1111/1462-2920.12599

24. 24.

    Shoaie S.. Quantifying diet-induced metabolic changes of the human gut microbiome. Cell Metab. 22, 320–331 (2015 ).

    Not in our library10.1016/j.cmet.2015.07.001

25. 25.

    Magnusdottir S.. Generation of genome-scale metabolic reconstructions for 773 members of the human gut microbiota. Nat. Biotechnol. 35, 81–89 (2017 ).

    Not in our library10.1038/nbt.3703

26. 26.

    Karlsson F. H.. Gut metagenome in European women with normal, impaired and diabetic glucose control. Nature 498, 99–103 (2013 ).

    Not in our library10.1038/nature12198

27. 27.

    Thiele I.. A community-driven global reconstruction of human metabolism. Nat. Biotechnol. 31, 419–425 (2013 ).

    Not in our library10.1038/nbt.2488

28. 28.

    Markle J. G.. Sex differences in the gut microbiome drive hormone-dependent regulation of autoimmunity. Science 339, 1084–1088 (2013 ).

    Not in our library10.1126/science.1233521

29. 29.

    Mueller S.. Differences in fecal microbiota in different European study populations in relation to age, gender, and country: a cross-sectional study. Appl. Environ. Microbiol. 72, 1027–1033 (2006 ).

    Not in our library10.1128/aem.72.2.1027-1033.2006

30. 30.

    Wu G. D.. Linking long-term dietary patterns with gut microbial enterotypes. Science 334, 105–108 (2011 ).

    Not in our library10.1126/science.1208344

31. 31.

    Noble D., Mathur R., Dent T., Meads C. & Greenhalgh T. Risk models and scores for type 2 diabetes: systematic review. BMJ 343, d7163 (2011 ).

    Not in our library10.1136/bmj.d7163

32. 32.

    Forslund K.. Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota. Nature 528, 262–266 (2015 ).

    Not in our library10.1038/nature15766

33. 33.

    Everard A.. Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc. Natl Acad. Sci. USA 110, 9066–9071 (2013 ).

    Not in our library10.1073/pnas.1219451110

34. 34.

    Everard A.. Responses of gut microbiota and glucose and lipid metabolism to prebiotics in genetic obese and diet-induced leptin-resistant mice. Diabetes 60, 2775–2786 (2011 ).

    Not in our library10.2337/db11-0227

35. 35.

    De Vadder F.. Microbiota-generated metabolites promote metabolic benefits via gut-brain neural circuits. Cell 156, 84–96 (2014 ).

    Not in our library10.1016/j.cell.2013.12.016

36. 36.

    Gao Z.. Butyrate improves insulin sensitivity and increases energy expenditure in mice. Diabetes 58, 1509–1517 (2009 ).

    Not in our library10.2337/db08-1637

37. 37.
    Butyrate and Propionate Protect against Diet-Induced Obesity and Regulate Gut Hormones via Free Fatty Acid Receptor 3-Independent Mechanisms · 2012

    No notice
38. 38.
    The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism · 2013

    Not checked
39. 39.

    Koh A., De Vadder F., Kovatcheva-Datchary P. & Backhed F. From dietary fiber to host physiology: short-chain fatty acids as key bacterial metabolites. Cell 165, 1332–1345 (2016 ).

    Not in our library10.1016/j.cell.2016.05.041

40. 40.
    Intestinal Short Chain Fatty Acids and their Link with Diet and Human Health · 2016

    No notice
41. 41.

    Wong J. M., de Souza R., Kendall C. W., Emam A. & Jenkins D. J. Colonic health: fermentation and short chain fatty acids. J. Clin. Gastroenterol. 40, 235–243 (2006 ).

    Not in our library10.1097/00004836-200603000-00015

42. 42.

    Arpaia N.. Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature 504, 451–455 (2013 ).

    Not in our library10.1038/nature12726

43. 43.

    Honda K., Moto M., Uchida N., He F. & Hashizume N. Anti-diabetic effects of lactic acid bacteria in normal and type 2 diabetic mice. J. Clin. Biochem. Nutr. 51, 96–101 (2012 ).

    Not in our library10.3164/jcbn.11-07

44. 44.

    Attene-Ramos M. S., Wagner E. D., Plewa M. J. & Gaskins H. R. Evidence that hydrogen sulfide is a genotoxic agent. Mol. Cancer Res. 4, 9–14 (2006 ).

    Not in our library10.1158/1541-7786.mcr-05-0126

45. 45.

    Bartram H. P.. Proliferation of human colonic mucosa as an intermediate biomarker of carcinogenesis: effects of butyrate, deoxycholate, calcium, ammonia, and pH. Cancer Res. 53, 3283–3288 (1993 ).

    Not in our library

46. 46.

    Hughes R., Magee E. A. & Bingham S. Protein degradation in the large intestine: relevance to colorectal cancer. Curr. Issues Intest. Microbiol. 1, 51–58 (2000 ).

    Not in our library

47. 47.

    Leschelle X.. Isolation of pig colonic crypts for cytotoxic assay of luminal compounds: effects of hydrogen sulfide, ammonia, and deoxycholic acid. Cell Biol. Toxicol. 18, 193–203 (2002 ).

    Not in our library10.1023/a:1015515821390

48. 48.

    David L. A.. Diet rapidly and reproducibly alters the human gut microbiome. Nature 505, 559–563 (2014 ).

    Not in our library10.1038/nature12820

49. 49.

    Truong D. T.. MetaPhlAn2 for enhanced metagenomic taxonomic profiling. Nat. Methods 12, 902–903 (2015 ).

    Not in our library10.1038/nmeth.3589

50. 50.

    Albenberg L.. Correlation between intraluminal oxygen gradient and radial partitioning of intestinal microbiota. Gastroenterology 147, 1055–1063 e1058 (2014 ).

    Not in our library10.1053/j.gastro.2014.07.020

51. 51.

    Baughn A. D. & Malamy M. H. The strict anaerobe Bacteroides fragilis grows in and benefits from nanomolar concentrations of oxygen. Nature 427, 441–444 (2004 ).

    Not in our library10.1038/nature02285

52. 52.

    Khan M. T.. The gut anaerobe Faecalibacterium prausnitzii uses an extracellular electron shuttle to grow at oxic-anoxic interphases. ISME J. 6, 1578–1585 (2012 ).

    Not in our library10.1038/ismej.2012.5

53. 53.

    Ma L.. Gene-targeted microfluidic cultivation validated by isolation of a gut bacterium listed in Human Microbiome Project's Most Wanted taxa. Proc. Natl Acad. Sci. USA 111, 9768–9773 (2014 ).

    Not in our library10.1073/pnas.1404753111

54. 54.

    Rettedal E. A., Gumpert H. & Sommer M. O. Cultivation-based multiplex phenotyping of human gut microbiota allows targeted recovery of previously uncultured bacteria. Nat. Commun. 5, 4714 (2014 ).

    Not in our library10.1038/ncomms5714

55. 55.

    Bakken J. S.. Treating Clostridium difficile infection with fecal microbiota transplantation. Clin. Gastroenterol. Hepatol. 9, 1044–1049 (2011 ).

    Not in our library10.1016/j.cgh.2011.08.014

56. 56.

    Rohlke F. & Stollman N. Fecal microbiota transplantation in relapsing Clostridium difficile infection. Therap. Adv. Gastroenterol. 5, 403–420 (2012 ).

    Not in our library10.1177/1756283x12453637

57. 57.
    Emergent biosynthetic capacity in simple microbial communities. · 2014

    Not checked
58. 58.

    Freilich S.. Competitive and cooperative metabolic interactions in bacterial communities. Nat. Commun. 2, 589 (2011 ).

    Not in our library10.1038/ncomms1597

59. 59.

    Harcombe W. R.. Metabolic resource allocation in individual microbes determines ecosystem interactions and spatial dynamics. Cell Rep. 7, 1104–1115 (2014 ).

    Not in our library10.1016/j.celrep.2014.03.070

60. 60.

    Buffie C. G.. Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile. Nature 517, 205–208 (2015 ).

    Not in our library10.1038/nature13828

61. 61.
    Inferring dynamic signatures of microbes in complex host ecosystems. · 2012

    Not checked
62. 62.
    On the Origins and Control of Community Types in the Human Microbiome. · 2016

    Not checked
63. 63.
    Ecological Modeling from Time-Series Inference: Insight into Dynamics and Stability of Intestinal Microbiota · 2013

    No notice
64. 64.
    Lateral gene transfer of an ABC transporter complex between major constituents of the human gut microbiome · 2012

    Not checked
65. 65.

    Stecher B.. Gut inflammation can boost horizontal gene transfer between pathogenic and commensal Enterobacteriaceae. Proc. Natl Acad. Sci. USA 109, 1269–1274 (2012 ).

    Not in our library10.1073/pnas.1113246109

66. 66.

    Sung J., Hale V., Merkel A. C., Kim P.-J. & Chia N. Metabolic modeling with big data and the gut microbiome. Appl. Transl. Genom. 10, 10–15 (2016 ).

    Not in our library10.1016/j.atg.2016.02.001

67. 67.

    Segata N.. Metagenomic microbial community profiling using unique clade-specific marker genes. Nat. Methods 9, 811–814 (2012 ).

    Not in our library10.1038/nmeth.2066

68. 68.
    Global metabolic interaction network of the human gut microbiota for context-specific community-scale analysis · 2017

    No notice
69. 69.

    Kanehisa M., Furumichi M., Tanabe M., Sato Y. & Morishima K. KEGG: new perspectives on genomes, pathways, diseases and drugs. Nucleic Acids Res. 45, D353–D361 (2017 ).

    Not in our library10.1093/nar/gkw1092

70. 70.
    Harnessing the landscape of microbial culture media to predict new organism–media pairings · 2015

    No notice

Cited by papers we hold 13

• Effects of Probiotics on Gut Microbiota: An Overview · 2024
  No notice
• Gut Microbial Metabolite Butyrate and Its Therapeutic Role in Inflammatory Bowel Disease: A Literature Review · 2023
  No notice
• Genome-scale metabolic reconstruction of 7,302 human microorganisms for personalized medicine · 2023
  No notice
• Small molecule modulation of microbiota: a systems pharmacology perspective · 2022
  Not checked
• Plasma metabolomic profiling in patients with rheumatoid arthritis identifies biochemical features predictive of quantitative disease activity · 2021
  Not checked
• Metabolomics and Multi-Omics Integration: A Survey of Computational Methods and Resources · 2020
  No notice
• A predictive index for health status using species-level gut microbiome profiling · 2020
  No notice
• Gut Microbiota Metabolism and Interaction with Food Components · 2020
  No notice
• Adjusting for age improves identification of gut microbiome alterations in multiple diseases · 2020
  No notice
• Bacterial Metabolism and Antibiotic Efficacy · 2019
  No notice
• Advancing functional and translational microbiome research using meta-omics approaches · 2019
  No notice
• Exploring the Human Microbiome: The Potential Future Role of Next-Generation Sequencing in Disease Diagnosis and Treatment · 2019
  No notice
• Fast automated reconstruction of genome-scale metabolic models for microbial species and communities · 2018
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.